Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:01 AM
Ignite Modification Date:
2025-12-25 @ 3:01 AM
NCT ID:
NCT06217133
Eligibility Criteria:
Inclusion Criteria:
* All preterm infants between 28 and 32 weeks of gestation using nasal CPAP and who are at least 8 and at most 12 days old will be included in the study.
Exclusion Criteria:
* hemodynamic instability,
* hydroelectrolyte disorders that influence cardiac function,
* post-operative,
* congenital abnormalities,
* pulmonary hypertension,
* decompensated ductus arteriosus,
* untreated atelectasis,
* pneumothorax,
* newborns who are using drains, whether chest or abdominal,
* presence of necrotizing enterocolitis
* grade 3 nasal septum injury,
* signal captured without the necessary quality to be used in research,
* premature babies who, for whatever reason, do not have two collections carried out on consecutive days until the twelfth day of life.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
28 Weeks
Maximum Age:
32 Weeks
Study:
NCT06217133
Study Brief:
Protocol Section:
NCT06217133